These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24088726)

  • 1. Deeper insight into the reducing biotransformation of bupropion in the human liver.
    Skarydova L; Tomanova R; Havlikova L; Stambergova H; Solich P; Wsol V
    Drug Metab Pharmacokinet; 2014; 29(2):177-84. PubMed ID: 24088726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of bupropion by carbonyl reductases in liver and intestine.
    Connarn JN; Zhang X; Babiskin A; Sun D
    Drug Metab Dispos; 2015 Jul; 43(7):1019-27. PubMed ID: 25904761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonyl reduction of bupropion in human liver.
    Molnari JC; Myers AL
    Xenobiotica; 2012 Jun; 42(6):550-61. PubMed ID: 22339467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.
    Teitelbaum AM; Flaker AM; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():239-53. PubMed ID: 27318149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Drug Metab Dispos; 2013 Sep; 41(9):1671-8. PubMed ID: 23804523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
    Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
    Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion metabolism by human placenta.
    Wang X; Abdelrahman DR; Zharikova OL; Patrikeeva SL; Hankins GD; Ahmed MS; Nanovskaya TN
    Biochem Pharmacol; 2010 Jun; 79(11):1684-90. PubMed ID: 20109440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes.
    Bhattacharya C; Kirby D; Van Stipdonk M; Stratford RE
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):261-274. PubMed ID: 30298475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.
    Malátková P; Havlíková L; Wsól V
    Chem Biol Interact; 2014 Sep; 220():241-7. PubMed ID: 25063510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitro.
    Sager JE; Price LS; Isoherranen N
    Drug Metab Dispos; 2016 Oct; 44(10):1709-19. PubMed ID: 27495292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor.
    Ghosal A; Yuan Y; Tong W; Su AD; Gu C; Chowdhury SK; Kishnani NS; Alton KB
    Drug Metab Dispos; 2011 Mar; 39(3):510-21. PubMed ID: 21123164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ; Chang TK
    Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC assay for bupropion and its major metabolites in human plasma.
    Loboz KK; Gross AS; Ray J; McLachlan AJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):115-21. PubMed ID: 16011913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.
    Maser E; Stinner B; Atalla A
    Cancer Lett; 2000 Feb; 148(2):135-44. PubMed ID: 10695989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma.
    Teitelbaum AM; Flaker AM; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():101-113. PubMed ID: 26963497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.
    Fokina VM; Xu M; Rytting E; Abdel-Rahman SZ; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN
    Drug Metab Dispos; 2016 Nov; 44(11):1832-1838. PubMed ID: 27528039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.
    Skarydova L; Nobilis M; Wsól V
    Xenobiotica; 2013 Apr; 43(4):346-54. PubMed ID: 23020786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of bupropion by baboon hepatic and placental microsomes.
    Wang X; Abdelrahman DR; Fokina VM; Hankins GD; Ahmed MS; Nanovskaya TN
    Biochem Pharmacol; 2011 Aug; 82(3):295-303. PubMed ID: 21570381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.